公共预算支出进度创近5年同期新高｜财富周历 动态前瞻

A-share Market - The Hong Kong stock market's equity financing scale has approached HKD 300 billion since 2025, reaching HKD 287.98 billion, a year-on-year increase of 350.56% [2] - As of the end of Q2, the northbound capital's market value reached CNY 2.29 trillion, growing over 2% from the end of Q1, with a holding quantity of 123.51 billion shares, an increase of over 3% [3] - As of July 8, 27 A-share companies have disclosed acquisition plans for IPO candidates this year, a significant increase from 6 in the same period last year, attributed to policy benefits and market dynamics [3] - On July 7, the Shanghai Stock Exchange and China Securities Index Company announced the launch of several specialized indices on July 21, aimed at promoting innovation and specialization in the market [3] - As of July 6, 688 listed companies have received bank support for stock repurchase and increase loans, with a total loan amount exceeding CNY 135.86 billion, indicating a strong usage of new financial tools [3] Financial Policy - In the first five months of this year, the national general public budget expenditure progress reached a five-year high, with over CNY 2.1 trillion in new local government special bonds issued [4] - As of June 30, China's foreign exchange reserves stood at USD 33,174 billion, an increase of USD 32.2 billion from the end of May, marking 19 consecutive months above USD 3.2 trillion [4] - The private equity confidence index and willingness to increase positions have slightly improved in July, with over 90% of private equity firms holding positions above 50% as of the end of June [4][5] Economic Indicators - In the first half of the year, the national consumer price index (CPI) decreased by 0.1% year-on-year, while the producer price index (PPI) fell by 2.8% [7] - As of July 9, China's express delivery volume has exceeded 1 billion packages this year, 35 days earlier than in 2024, reflecting strong economic resilience [6] - In the first five months, China's exports to Africa, ASEAN, Latin America, and the EU grew by 20.2%, 13.5%, 10.6%, and 7.7% respectively, significantly outpacing overall export growth [7] Innovation and Development - In the first half of the year, China approved 43 innovative drugs and 45 innovative medical devices, representing year-on-year growth of 59% and 87% respectively, indicating a positive trend in the pharmaceutical industry [8]